Acorda Therapeutics, Inc.
Acorda Therapeutics is a 22 year old biotechnology company based in Westchester County, New York. The Company’s mission is to develop therapies that will restore function and improve the lives of people with neurological disorders. Acorda has a pipeline of neurological therapies addressing a range of disorders, including Parkinson’s disease, migraine and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.